Streetbeat News

Regulatory

TAL

TAL Education Group's stock fell by 5.30% due to China's central bank maintaining its loan prime rates, indicating a conservative monetary policy. This decision suggests limited economic stimulus, affecting companies like TAL that rely on economic growth for consumer spending on education services.

Portfolio Pulse from Henry Khederian

August 20, 2024 | 10:47 pm

TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP) shares fell 14.61% after a 60% gain, following Q2 results showing a larger-than-expected loss. The company initiated a Phase 2 trial for TNX-1300, a treatment for acute cocaine intoxication, and highlighted progress on its TNX-801 vaccine for mpox and smallpox.

Portfolio Pulse from Henry Khederian

August 20, 2024 | 10:36 pm

MDIA

MediaCo has received a non-compliance notification from Nasdaq due to a delayed filing of its quarterly report. This could impact the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:55 pm

MESA

Mesa Air Group has received a non-compliance notice from Nasdaq due to a delay in filing its quarterly report. The company is working to file the Form 10-Q before the 60-day notice period ends to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:14 pm

AADI

Aadi Bioscience announced that its PRECISION1 trial is unlikely to meet the regulatory threshold for accelerated approval and will be halted. The trial's Independent Data Monitoring Committee found it unlikely to exceed the necessary efficacy threshold. Patients benefiting from nab-sirolimus can transition to an expanded access protocol.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:03 pm

NEXT

NextDecade's subsidiary has withdrawn its application at the Federal Energy Regulatory Commission (FERC) for a proposed carbon capture and storage project at the Rio Grande LNG facility.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:01 pm

AVGO

DXCM

MRNA

NVDA

PDD

PODD

QQQ

SPY

XLE

XOM

The S&P 500 and Nasdaq 100 indices ended their 8-day winning streak due to a lack of economic data and hawkish comments from Fed Governor Michelle Bowman. Major drags included Nvidia, Exxon Mobil, and energy stocks, while some sectors like consumer staples and healthcare saw gains.

Portfolio Pulse from Piero Cingari

August 20, 2024 | 8:39 pm

AZTR

Azitra has initiated the enrollment of the first patient in a Phase 1b trial for ATR-12, a treatment for Netherton Syndrome. This marks a significant step in the development of their therapeutic pipeline.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:16 pm

GLPG

FMR LLC has notified Galapagos of holding 5.61% of its voting rights, maintaining a position above the 5% threshold. This includes 3,693,550 ordinary shares and 3,200 financial instruments. Changes in holdings were noted among FMR's controlled entities.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:05 pm

ENVB

Enveric Biosciences has been granted a US patent for 'C4-Carboxylic Acid-Substituted Tryptamine Derivatives and Methods Used to Treat Brain Neurological Disorders'. This patent could enhance their intellectual property portfolio and potentially impact their market position in neurological disorder treatments.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 7:54 pm